BDMD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Baird Medical Investment Holdings Ltd (BDMD) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows weak technical indicators, no significant trading signals, poor financial performance, and lacks strong positive catalysts to support a long-term growth outlook.
The MACD is negative and expanding, indicating bearish momentum. The RSI is at 25.308, which is close to oversold territory but still neutral. Moving averages are converging, showing no clear trend. The stock is trading below key support levels, with S1 at 1.761 and the current price at 1.7044, suggesting further downside risk.
The company is conducting clinical training workshops and expanding its presence in Southeast Asia, which may improve its market position in the long term.
and EPS (-0.43). Technical indicators suggest bearish momentum.
In 2024/Q2, the company showed no YoY growth in revenue, net income, or EPS. Net income remains negative, and while gross margin is high at 82.11, it has not translated into profitability.
No recent analyst ratings or price target changes are available for BDMD.
